Cell-cycle-associated expressions of proliferating cell nuclear antigen and Ki-67 reactive antigen of bone marrow blast cells in childhood acute leukemia

Leukemia

Volumn 6, Issue 7, 1992, Pages 669-674

  Tsurusawa, Masahito ^a   Ito, Mari ^a   Zha, Zhimin ^a   Kawai, Susumu ^a   Takasaki, Yoshinari ^b   Fujimoto, Takeo ^a  

^a AICHI MEDICAL UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; MONOCLONAL ANTIBODY KI 67;

ANTIGEN ANTIBODY REACTION; ANTIGEN EXPRESSION; ARTICLE; BLAST CELL; BONE MARROW; BONE MARROW CELL; CELL CYCLE G1 PHASE; CELL CYCLE PHASE; CELL CYCLE S PHASE; CELL GROWTH; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CYCLING; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL;

CELL CYCLE; CHILD; DNA, NEOPLASM; FLOW CYTOMETRY; HUMAN; KI-67 ANTIGEN; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, NONLYMPHOCYTIC, ACUTE; NUCLEAR PROTEINS; PROLIFERATING CELL NUCLEAR ANTIGEN;

EID: 0026769630     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983;31:13-20.
2. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133:1710-1715.
3. Gerdes J, Dallenbach F, Lennert K. Growth fractions in malignant non-Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67. Hematol Oncol 1984;2:365-371.
4. Barnard N, Hall PA, Lemoine NR, Kadar N. Proliferative index in breast carcinoma determined in situ by Ki-67 immunostaining and its relationship to clinical and pathological variables. J Pathol 1987;152:287-295.
5. Sasaki K, Matsumura K, Tsuji T, Shinozaki D, Takahashi M. Relationship between labeling indices of Ki-67 and BrdUrd in human malignant tumors. Cancer 1988;62: 989-993.
6. Falini B, Canino S, Sacchi S, Ciani C, Martelli MF, Gerdes J et al. Immunocytochemical evaluation of the Percentage of proliferating cells in pathological bone marrow and peripheral blood samples with the Ki-67 and anti-bromo-deoxyuridine monoclonal antibodies. Br J Haematol 1988;69:311-320.
7. Lokhorst HM, Boom SE, Terpstar W, Roholl P, Gerdes J, Bast BJE. Determination of the growth fraction in monoclonal gammopathy with the monoclonal antibody Ki-67. Br J Haematol 1988;69:477-481.
8. Nishizaki T, Orita T, Furutani Y, Ikeyama Y, Aoki H, Sasaki. Flow-cytometric DNA analysis and immunohistochemical measurement of Ki-67 and BrdUrd labeling indices in human brain tumors. J Neurosurg 1989;70: 379-384.
9. Yonemura Y, Ooyama S, Sugiyama K, Ninomiya I, Kamata T, Yamaguchi A et al. Growth fractions in gastric carcinomas determined with monoclonal antibody with Ki-67. Cancer 1990;65:1130-1134.
10. Isola JJ, Helin HJ, Helle MJ, Kallioniemi OP. Evaluation of cell proliferation in breast carcinoma; Comparison of Ki-67 immunohistochemical study, DNA flow cytometric analysis, and mitotic count. Cancer 1990;65:1180-1184.
11. Miyachi K, Fritzler MJ, Tan EM. Autoantibody to a nuclear antigen in proliferating cells. J Immunol 1978; 121:2228-2234.
12. Takasaki Y, Fishwild D, Tan EM. Characterization of proliferating cell nuclear antigen recognized by autoantibodies in lupus sera. J Exp Med 1984;159:981-992.
13. Ogata K, Ogata Y, Nakamura RM, Tan EM. Purification and N-terminal amino acid sequence of proliferating cell nuclear antigen (PCNA)/cyclin and development of ELISA for anti-PCNA antibodies. J Immunol 1985;135: 2623-2627.
14. Bravo R, Celis JE. A search for differential polypeptide : synthesis throughout the cell cycle of HeLa cells. J Cell Biol 1980;84:795-802.
15. Mathews MB, Bernstein RM, Franza Jr. RB, Garrels JJ. Identity of proliferating cell nuclear antigen and cyclin. Nature 1984;309:374-376.
16. Bravo R, Frank R, Blundel PA, Bravo HM. Cyclin/ PCNA is the auxiliary protein of DNA polymerase-delta. Nature 1987;326:515-517.
17. Jaskulski D, DeRiel JK, Mercer WE, Calabretta B, Baserga R. Inhibition of cellular proliferation by antisense oligodeoxynucleotides to PCNA/cyclin. Science 1988; 240:1544-1546.
18. Ogata K, Kurki P, Celis JE, Nakamura RM, Tan EM. Monoclonal antibodies to a nuclear protein (PCNA/ cyclin) associated with DNA replication. Exp Cell Res 1987;168:475-486.
19. Takasaki Y, Ohgaki M, Kodama A, Ogata K, Hashimoto H, Shirai T, Hirose S. A sandwich type enzyme-linked immunosorbent assay for proliferating cell nuclear antigen (PCNA)/cyclin using monoclonal antibodies. J Immunol Methods 1990;132:227-237.
20. Garcia RL, Coltrera MC, Gown AM. Analysis of proliferative grade using anti PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Am J Pathol 1989; 134:733-739.
21. Miyagawa S, Okada N, Takasaki Y, Iida T, Kitano Y, Yoshikawa K, Sakamoto K, Steinberg ML. Expression of proliferating cell nuclear antigen/cyclin in human kerationocytes. J Invest Dermatol 1989;93:678-681.
22. Dawson AE, Norton JA, Weinberg DS. Comparative assessment of proliferation and DNA content in breast carcinoma by image analysis and flow cytometry. Am J Pathol 1990;136:1115-1124.
23. Kamel OW, LeBrun DP, Davis RE, Berry GJ, Warnke RA. Growth fraction estimation of malignant lymphomas in formalin-fixed paraffin-embedded tissue using antiPCNA/cyclin 19A2. Am J Pathol 1991;138:1471-1477.
24. Kurki P, Ogata K, Tan EM. Monoclonal antibodies to proliferating cell nuclear antigen (PCNA/cyclin) as probes for proliferating cells by immunofluorescence microscopy and flow cytometry. J Immunol Methods 1988;109:49-59.
25. Liu YC, Marraccino RL, Keng PC, Bambara RA, Lord EM, Chou WG, Zain SB. Requirement for proliferating cell nuclear antigen expression during stage the of the chinese hamster ovary cell cycle. Biochemistry 1989;28: 2967-2974.
26. Landberg G, Tan EM, Roos G. Flow cytometric multiparameter analysis of proliferating cell nuclear antigen/ cyclin and Ki-67 antigen: a new view of the cell cycle. Exp Cell Res 1990;187:111-118.
27. Tsurusawa M, Kaneko Y, Katano N, Niwa M, Ito M, Fujimoto T. Flow cytometric evidence for minimal residual disease and cytological heterogeneities in acute lymphoblastic leukemia with severe hypoploidy. Am J Hematol 1989;32:42-49.
28. Sasaki K, Murakami M, Kawasaki M, Takahashi M. The cell cycle associated change of the Ki-67 reactive nuclear antigen expression. J Cell Physiol 1987;133:579-584.
29. Dean PN. A simplified method for DNA distribution analysis. Cell Tissue Kinet 1980;13:299-308.
30. Smetana K, Gyorkey F, Chan PK, Tan E, Busch H. Proliferating cell nuclear antigen (PCNA) and human malignant tumor nucleolar antigens (HMTNA) in nucleoli of human hematological malignancies. Blut 1983;46: 133-143.
31. Takasaki Y, Deng JS, Tan EM. A nuclear antigen associated with cell proliferation and blast transformation. J Exp Med 1981;154:1899-1909.
32. Kurki P, Vanderlaan M, Dolbeare F, Gray J, Tan EM. Expression of proliferating cell nuclear antigen (PCNA)/ cyclin during the cell cycle. Exp Cell Res 1986;166: 209-219.
33. Kurki P, Lotz M, Ogata K, Tan EM. Proliferating cell nuclear antigen (PCNA)/cyclin in activated human T lymphocytes. J Immunol 1987;138:4114-4120.
34. Bravo R, Bravo HM. Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: association with DNA replication sites. J Cell Biol 1987;105:1549-1554.
35. Shipman RM, Sabath DE, Fischer AH, Comber PG, Sullivan K, Tan EM et al. Cyclin mRNA and protein expression in recombinant interleukin 2-stimulated cloned murine T lymphocytes. J Cell Biochem 1988;38:189-198.
36. Van Dierendonck JH, Wijsman JH, Keijzer R, Cornells JH, Van de Velde, Cornelisse CJ. Cell-cycle, related staining patterns of anti-proliferating cell nuclear antigen monoclonal antibodies. Am J Pathol 1991;138: 1165-1172.
37. Keim D, Hailat N, Hodge D, Hanash SM. Proliferating cell nuclear antigen expression in childhood acute leukemia. Blood 1990;76:985-990.
38. Scott CS, Ramsden W, Limbert HJ, Master PS, Robert BE. Membrane transferrin receptor (TfR) and nuclear proliferation-associated Ki-67 expression in hemopoietic malignancies. Leukemia 1988;2:438-442.
39. Drach J, Gattringer C, Glassl H, Schwarting R, Stein H, Huber H. Simultaneous flow cytometric analysis of surface markers and nuclear antigen in leukemia and lymphoma. Cytometry 1989;10:743-749.
40. Dierendonck JH, Keijzer R, Cornells JH, Cornelisse CJ. Nuclear distribution of the Ki-67 antigen during the cell cycle: comparison with growth fraction in human breast cancer cells. Cancer Res 1989;49:2999-3006.
41. Lopez F, Belloc F, Lacombe F, Dumain P, Reiffers J, Bernard P, Boisseau MR. Modalities of synthesis of Ki-67 antigen during the stimulation of lymphocytes. Cytometry 1991;12:42-49.
42. Sasaki K, Matsumura K, Murakami T, Shinozaki F, Takahashi M. Effect of serum deprivation on Ki-67-reactive antigen expression in HeLa cells. Acta Pathol Jpn 1989;39:638-642.
43. Baisch H, Gerdes J. Simultaneous staining of exponentially growing versus plateau phase cells with proliferation-associated antibody Ki-67 and propidium iodide: analysis by flow cytometry. Cell Tissue Kinet 1987;20:387-391.
44. Wersto RP, Herz F, Gallagher RE, Koss LG. Cell cycle-dependent reactivity with monoclonal antibody Ki-67 during myeloid cell differentiation. Exp Cell Res 1988; 179:79-88.
45. Silverstrini R, Costa A, Veneroni S, Bino D, Persici. Comparative analysis of different approaches to investigate cell kinetics. Cell Tissue Kinet 1988;21: 123-131.
46. Walker RA, Camplejohn RS. Comparison of monoclonal antibody Ki-67 reactivity with grade and DNA flow cytometry of breast carcinomas. Br J Cancer 1988;57: 281-283.
47. Van'Bockstele, Lan J, Snoeck HW, Korthout ML, DeBock RF, Peetermans ME. Abberant Ki-67 expression in normal bone marrow revealed by multiparameter flow cytometric analysis. Cytometry 1991;12:50-63.